{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:19:39Z","timestamp":1787876379034,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57339-y","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:04:20Z","timestamp":1781370260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Collagen gene expression profiles predict recurrence and progression of DCIS to IDC"],"prefix":"10.1038","volume":"16","author":[{"given":"Naeimeh","family":"Heiranizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Mohammad-rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Noroozbeygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Azad","family":"Armaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Aziminezhadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil Rahmani","family":"Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh Shateri","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Nafissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kadivar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"3","key":"57339_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer. J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"J. Clin."},{"issue":"3","key":"57339_CR2","first-page":"287","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J. Natl. Cancer Cent. 5 (3), 287\u2013296 (2025).","journal-title":"J. Natl. Cancer Cent."},{"key":"57339_CR3","first-page":"e911","volume":"4","author":"H Sadeghi-Gandomani","year":"2017","unstructured":"Sadeghi-Gandomani, H. et al. Lung cancer in the world: the incidence, mortality rate and risk factors. World Cancer Res. J. 4, e911 (2017).","journal-title":"World Cancer Res. J."},{"key":"57339_CR4","unstructured":"Ellberg, C. Insights into breast cancer. (2014)."},{"key":"57339_CR5","unstructured":"Wang, Y. Literature-based discovery of known and potential new mechanisms for relating the status of cholesterol to the progression of breast cancer (University of Illinois at Urbana-Champaign, 2019)."},{"issue":"1","key":"57339_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41392-024-01779-3","volume":"9","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance. Signal. Transduct. Target. therapy. 9 (1), 83 (2024).","journal-title":"Signal. Transduct. Target. therapy"},{"key":"57339_CR7","doi-asserted-by":"crossref","unstructured":"Nafissi, N. et al. Breast Conserving Surgery and Intraoperative Electron Radiotherapy (IOERT) Among Cases of Ductal Carcinoma In Situ. Arch. Breast Cancer :79\u201384. (2019).","DOI":"10.32768\/abc.20196279-84"},{"issue":"9472","key":"57339_CR8","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"EBCTC Group","year":"2005","unstructured":"Group, E. B. C. T. C. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (9472), 1687\u20131717 (2005).","journal-title":"Lancet"},{"issue":"10","key":"57339_CR9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1541-7786.MCR-22-1004","volume":"21","author":"ED Sunassee","year":"2023","unstructured":"Sunassee, E. D., Jardim-Perassi, B. V., Madonna, M. C., Ordway, B. & Ramanujam, N. Metabolic imaging as a tool to characterize chemoresistance and guide therapy in Triple-Negative Breast Cancer (TNBC). Mol. Cancer Res. 21 (10), 995\u20131009 (2023).","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"57339_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","volume":"22","author":"Z Yuan","year":"2023","unstructured":"Yuan, Z. et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol. Cancer. 22 (1), 48 (2023).","journal-title":"Mol. Cancer"},{"key":"57339_CR11","doi-asserted-by":"publisher","first-page":"115390","DOI":"10.1016\/j.biopha.2023.115390","volume":"166","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q., An, Z-Y., Jiang, W., Jin, W-L. & He, X-Y. Collagen code in tumor microenvironment: Functions, molecular mechanisms, and therapeutic implications. Biomed. Pharmacother. 166, 115390 (2023).","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"57339_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139 (5), 891\u2013906 (2009).","journal-title":"Cell"},{"issue":"4","key":"57339_CR13","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3892\/ijo.2014.2562","volume":"45","author":"Z Fu","year":"2014","unstructured":"Fu, Z. et al. Cancer-associated fibroblasts from invasive breast cancer have an attenuated capacity to secrete collagens. Int. J. Oncol. 45 (4), 1479\u20131488 (2014).","journal-title":"Int. J. Oncol."},{"issue":"1","key":"57339_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s40944-024-00935-5","volume":"23","author":"BS Amiri","year":"2025","unstructured":"Amiri, B. S., Maddah, R. & Nafissi, N. Investigating the genes and molecular pathways involved in the progression of ductal carcinoma in situ to invasive breast cancer: A bioinformatics approach. Indian J. Gynecologic Oncol. 23 (1), 34 (2025).","journal-title":"Indian J. Gynecologic Oncol."},{"issue":"11","key":"57339_CR15","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1172\/JCI33295","volume":"117","author":"K Polyak","year":"2007","unstructured":"Polyak, K. Breast cancer: origins and evolution. J. Clin. Investig. 117 (11), 3155\u20133163 (2007).","journal-title":"J. Clin. Investig."},{"issue":"4","key":"57339_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu, P., Weaver, V. M. & Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196 (4), 395\u2013406 (2012).","journal-title":"J. Cell Biol."},{"issue":"12","key":"57339_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup, M. W., Mouw, J. K. & Weaver, V. M. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 15 (12), 1243\u20131253 (2014).","journal-title":"EMBO Rep."},{"issue":"1","key":"57339_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1741-7015-6-11","volume":"6","author":"PP Provenzano","year":"2008","unstructured":"Provenzano, P. P. et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 6 (1), 11 (2008).","journal-title":"BMC Med."},{"issue":"5","key":"57339_CR19","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/jcm11051250","volume":"11","author":"A Lepucki","year":"2022","unstructured":"Lepucki, A. et al. The role of extracellular matrix proteins in breast cancer. J. Clin. Med. 11 (5), 1250 (2022).","journal-title":"J. Clin. Med."},{"issue":"4","key":"57339_CR20","doi-asserted-by":"publisher","first-page":"M111","DOI":"10.1074\/mcp.M111.014647","volume":"11","author":"A Naba","year":"2012","unstructured":"Naba, A. et al. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell. Proteom. 11 (4), M111 (2012).","journal-title":"Mol. Cell. Proteom."},{"issue":"7","key":"57339_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12032-017-0986-2","volume":"34","author":"EM Ibrahim","year":"2017","unstructured":"Ibrahim, E. M., Al-Hajeili, M. R., Bayer, A. M., Abulkhair, O. A. & Refae, A. A. Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials. Med. Oncol. 34 (7), 131 (2017).","journal-title":"Med. Oncol."},{"key":"57339_CR22","doi-asserted-by":"crossref","unstructured":"Klijn, J. G., Berns, E. M. & Foekens, J. A. Prognostic and predictive factors and targets for therapy in breast cancer. p. 115\u2013146 (CRC, 2002).","DOI":"10.3109\/9780203909249-7"},{"issue":"3","key":"57339_CR23","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.ajpath.2010.11.076","volume":"178","author":"MW Conklin","year":"2011","unstructured":"Conklin, M. W. et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am. J. Pathol. 178 (3), 1221\u20131232 (2011).","journal-title":"Am. J. Pathol."},{"issue":"3","key":"57339_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10549-015-3288-4","volume":"149","author":"L-Y Chen","year":"2015","unstructured":"Chen, L-Y. et al. Bcl2 and Ki67 refine prognostication in luminal breast cancers. Breast Cancer Res. Treat. 149 (3), 631\u2013643 (2015).","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"57339_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.breast.2009.02.009","volume":"18","author":"FG Wiesner","year":"2009","unstructured":"Wiesner, F. G. et al. Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients. Breast 18 (2), 135\u2013141 (2009).","journal-title":"Breast"},{"key":"57339_CR26","doi-asserted-by":"crossref","unstructured":"Shao, Z-M., Jiang, Y-Z., Liu, Z. J. & Zhou, S. Predictive, Prognostic Biomarkers and Therapeutic Targets in Breast Cancer. (Frontiers Media SA, 2022).","DOI":"10.3389\/978-2-83250-101-6"},{"issue":"8","key":"57339_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3319","volume":"12","author":"HE Barker","year":"2012","unstructured":"Barker, H. E., Cox, T. R. & Erler, J. T. The rationale for targeting the LOX family in cancer. Nat. Rev. Cancer 12 (8), 540\u2013552 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"57339_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","volume":"58","author":"E Conte","year":"2014","unstructured":"Conte, E. et al. Effect of pirfenidone on proliferation, TGF-\u03b2-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. Eur. J. Pharm. Sci. 58, 13\u201319 (2014).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"57339_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer. 10 (1), 9\u201322 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"57339_CR30","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.breast.2013.07.012","volume":"22","author":"T Oskarsson","year":"2013","unstructured":"Oskarsson, T. Extracellular matrix components in breast cancer progression and metastasis. Breast 22, S66\u2013S72 (2013).","journal-title":"Breast"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57339-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:04:56Z","timestamp":1787875496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57339-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57339"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57339-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27067"}}